Pharmacokinetics and toxicokinetics / (Record no. 48853)

MARC details
000 -LEADER
fixed length control field 02269cmm a2200241 a 4500
001 - CONTROL NUMBER
control field 46843
003 - CONTROL NUMBER IDENTIFIER
control field IN-BdCUP
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230426175601.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230426s2023 u eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781482221350
040 ## - CATALOGING SOURCE
Language of cataloging eng
Transcribing agency IN-BdCUP
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.700
Item number B736
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Boroujerdi, Mehdi
Relator term Author
245 #0 - TITLE STATEMENT
Title Pharmacokinetics and toxicokinetics /
Statement of responsibility, etc. Mehdi Boroujerdi, College of Health Sciences - School of Pharmacy, University of Massachusetts Lowell, Lowell, Massachusetts USA
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Boca Raton, Florida :
Name of publisher, distributor, etc. CRC Press :;Taylor & Francis Group,
Date of publication, distribution, etc. [2015];©2015
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note chapter 1. The influence of routes of administration on ADME -- chapter 2. Mechanisms of absorption and permeation of xenobiotics -- chapter 3. In Vivo distribution of xenobiotics -- chapter 4. Elimination rate, clearance, and the theoretical models -- chapter 5. Renal excretion of xenobiotics and estimation of related PK/TK parameters and constants -- chapter 6. Biotransformation of xenobiotics -- chapter 7. Kinetics of In Vitro metabolism : assimilation of intrinsic clearance in hepatic clearance -- chapter 8. Pharmaceutical, biopharmaceutical, and physiological factors influencing oral absorption : mechanistic absorption models -- chapter 9. Mathematical modeling in pharmacokinetics and toxicokinetics -- chapter 10. PK/TK analysis of instantaneous exposure to xenobiotics (single bolus injection) -- chapter 11. PK/TK analysis of continuous zero-order exposure to xenobiotics (intravenous infusion) -- chapter 12. PK/TK analysis of xenobiotics absorbed via an extravascular route of administration (oral administration) -- chapter 13. PK/TK of xenobiotics absorbed through the skin (transdermal absorption) -- chapter 14. PK/TK analysis of multiple dosing -- chapter 15. Bioavailability, bioequivalence, and biosimilar evaluations -- chapter 16. Preclinical PK/TK and clinical trials -- chapter 17. Population pharmacokinetics/toxicokinetics -- chapter 18. Quantitative extrapolation interspecies scaling/low dose extrapolation
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacokinetics
Topical term or geographic name entry element Xenobiotics
856 ## - ELECTRONIC LOCATION AND ACCESS
Materials specified Electronic Book Resource
Uniform Resource Identifier <a href="https://www.taylorfrancis.com/books/9781482221350">https://www.taylorfrancis.com/books/9781482221350</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type E-Book
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Source of acquisition Total checkouts Full call number Barcode Date last seen Uniform resource identifier Bill Date Koha item type
    Dewey Decimal Classification     Ranganathan Library Ranganathan Library 07/04/2022 Taylor & Francis   615.700 B736 E01447 26/04/2023 https://www.taylorfrancis.com/books/9781482221350 07/04/2022 E-Book
This system is made operational by the in-house staff of the CUP Library.